Prevention and Treatment of Atherosclerosis : Improving State-of-the-Art Management and Search for Novel Targets / / edited by Arnold von Eckardstein, Christoph J. Binder.
This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding in...
Saved in:
Superior document: | Handbook of Experimental Pharmacology, 270 |
---|---|
: | |
TeilnehmendeR: | |
Place / Publishing House: | Cham : : Springer International Publishing :, Imprint: Springer,, 2022. |
Year of Publication: | 2022 |
Edition: | 1st ed. 2022. |
Language: | English |
Series: | Handbook of Experimental Pharmacology,
270 |
Physical Description: | 1 online resource (537 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993544793204498 |
---|---|
ctrlnum |
(CKB)5670000000200408 (MiAaPQ)EBC6877842 (Au-PeEL)EBL6877842 (OCoLC)1295275583 (oapen)https://directory.doabooks.org/handle/20.500.12854/78275 (DE-He213)978-3-030-86076-9 (PPN)272258202 (EXLCZ)995670000000200408 |
collection |
bib_alma |
record_format |
marc |
spelling |
Eckardstein, Arnold von. Prevention and Treatment of Atherosclerosis [electronic resource] : Improving State-of-the-Art Management and Search for Novel Targets / edited by Arnold von Eckardstein, Christoph J. Binder. 1st ed. 2022. Cham : Springer International Publishing : Imprint: Springer, 2022. 1 online resource (537 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Handbook of Experimental Pharmacology, 1865-0325 ; 270 English This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. . Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics. Open Access Internal medicine. Pharmacology. Diseases. Internal Medicine. Arterioesclerosi thub Terapèutica thub Medicina preventiva thub Llibres electrònics thub 3-030-86075-2 Binder, Christoph J. |
language |
English |
format |
Electronic eBook |
author |
Eckardstein, Arnold von. |
spellingShingle |
Eckardstein, Arnold von. Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets / Handbook of Experimental Pharmacology, Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics. |
author_facet |
Eckardstein, Arnold von. Binder, Christoph J. |
author_variant |
a v e av ave |
author2 |
Binder, Christoph J. |
author2_variant |
c j b cj cjb |
author2_role |
TeilnehmendeR |
author_sort |
Eckardstein, Arnold von. |
title |
Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets / |
title_sub |
Improving State-of-the-Art Management and Search for Novel Targets / |
title_full |
Prevention and Treatment of Atherosclerosis [electronic resource] : Improving State-of-the-Art Management and Search for Novel Targets / edited by Arnold von Eckardstein, Christoph J. Binder. |
title_fullStr |
Prevention and Treatment of Atherosclerosis [electronic resource] : Improving State-of-the-Art Management and Search for Novel Targets / edited by Arnold von Eckardstein, Christoph J. Binder. |
title_full_unstemmed |
Prevention and Treatment of Atherosclerosis [electronic resource] : Improving State-of-the-Art Management and Search for Novel Targets / edited by Arnold von Eckardstein, Christoph J. Binder. |
title_auth |
Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets / |
title_new |
Prevention and Treatment of Atherosclerosis |
title_sort |
prevention and treatment of atherosclerosis improving state-of-the-art management and search for novel targets / |
series |
Handbook of Experimental Pharmacology, |
series2 |
Handbook of Experimental Pharmacology, |
publisher |
Springer International Publishing : Imprint: Springer, |
publishDate |
2022 |
physical |
1 online resource (537 pages) |
edition |
1st ed. 2022. |
contents |
Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics. |
isbn |
3-030-86076-0 3-030-86075-2 |
issn |
1865-0325 ; |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC1-1245 |
callnumber-sort |
RC 11 41245 |
genre |
Llibres electrònics thub |
genre_facet |
Llibres electrònics |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616 |
dewey-sort |
3616 |
dewey-raw |
616 |
dewey-search |
616 |
oclc_num |
1295275583 |
work_keys_str_mv |
AT eckardsteinarnoldvon preventionandtreatmentofatherosclerosisimprovingstateoftheartmanagementandsearchfornoveltargets AT binderchristophj preventionandtreatmentofatherosclerosisimprovingstateoftheartmanagementandsearchfornoveltargets |
status_str |
n |
ids_txt_mv |
(CKB)5670000000200408 (MiAaPQ)EBC6877842 (Au-PeEL)EBL6877842 (OCoLC)1295275583 (oapen)https://directory.doabooks.org/handle/20.500.12854/78275 (DE-He213)978-3-030-86076-9 (PPN)272258202 (EXLCZ)995670000000200408 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Handbook of Experimental Pharmacology, 270 |
hierarchy_sequence |
270 |
is_hierarchy_title |
Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets / |
container_title |
Handbook of Experimental Pharmacology, 270 |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1797815017063579648 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03195nam a22006135i 4500</leader><controlfield tag="001">993544793204498</controlfield><controlfield tag="005">20240429155227.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr#cnu||||||||</controlfield><controlfield tag="008">220131s2022 sz | o |||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-030-86076-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-030-86076-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5670000000200408</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)EBC6877842</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL6877842</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1295275583</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/78275</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-He213)978-3-030-86076-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PPN)272258202</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995670000000200408</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC1-1245</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MJ</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED010000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MJ</subfield><subfield code="2">thema</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Eckardstein, Arnold von.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prevention and Treatment of Atherosclerosis</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">Improving State-of-the-Art Management and Search for Novel Targets /</subfield><subfield code="c">edited by Arnold von Eckardstein, Christoph J. Binder.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2022.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing :</subfield><subfield code="b">Imprint: Springer,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (537 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Handbook of Experimental Pharmacology,</subfield><subfield code="x">1865-0325 ;</subfield><subfield code="v">270</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. .</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics.</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="a">Open Access</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Internal medicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Diseases.</subfield></datafield><datafield tag="650" ind1="1" ind2="4"><subfield code="a">Internal Medicine.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Internal Medicine.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Diseases.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Arterioesclerosi</subfield><subfield code="2">thub</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Terapèutica</subfield><subfield code="2">thub</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicina preventiva</subfield><subfield code="2">thub</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Llibres electrònics</subfield><subfield code="2">thub</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-030-86075-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Binder, Christoph J.</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Handbook of Experimental Pharmacology,</subfield><subfield code="x">1865-0325 ;</subfield><subfield code="v">270</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-05-01 02:50:03 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-02-12 19:07:41 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337700520004498&Force_direct=true</subfield><subfield code="Z">5337700520004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337700520004498</subfield></datafield></record></collection> |